|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
180,310,000 |
Market
Cap: |
41.24(B) |
Last
Volume: |
799,597 |
Avg
Vol: |
865,224 |
52
Week Range: |
$191.51 - $228.9 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Seagen is a biotechnology company that develops and commercializes targeted therapies to treat cancer. Co. is commercializing ADCETRIS®, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas, PADCEV®, or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers, TIVDAK, or tisotumab vedotin-tftv, for the treatment of certain metastatic cervical cancers, and TUKYSA®, or tucatinib, for treatment of certain metastatic HER2-positive breast cancers. Co. is also developing a pipeline of therapies for solid tumors and blood-related cancers designed to address unmet medical needs and improve treatment outcomes for patients.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) ![](../../images/information.jpg) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
39,326 |
484,602 |
Total Sell Value |
$0 |
$0 |
$8,245,949 |
$88,100,996 |
Total People Sold |
0 |
0 |
7 |
8 |
Total Sell Transactions |
0 |
0 |
18 |
70 |
End Date |
2024-03-24 |
2023-12-22 |
2023-06-23 |
2022-06-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Liu Jean I |
EVP, Legal Affairs & GC |
|
2014-12-01 |
4 |
A |
$0.00 |
$0 |
D/D |
22,400 |
22,400 |
|
- |
|
Siegall Clay B |
President and CEO |
|
2014-11-25 |
5 |
GD |
$0.00 |
$0 |
D/D |
2,688 |
557,022 |
|
- |
|
Himes Vaughn B |
EVP, Tech. Ops. & Proc. Sci. |
|
2014-11-12 |
4 |
S |
$37.52 |
$375,169 |
D/D |
(10,000) |
67,209 |
|
- |
|
Himes Vaughn B |
EVP, Tech. Ops. & Proc. Sci. |
|
2014-11-12 |
4 |
OE |
$9.23 |
$92,300 |
D/D |
10,000 |
77,209 |
|
- |
|
14159, L.p. |
Director |
|
2014-11-10 |
4 |
B |
$35.88 |
$8,787,529 |
I/I |
241,249 |
19,861,870 |
2.25 |
- |
|
14159, L.p. |
Director |
|
2014-11-07 |
4 |
B |
$34.91 |
$7,561,461 |
I/I |
211,704 |
19,620,621 |
2.25 |
- |
|
14159, L.p. |
Director |
|
2014-11-06 |
4 |
B |
$33.71 |
$40,805,169 |
I/I |
1,200,972 |
19,408,917 |
2.25 |
- |
|
Siegall Clay B |
President and CEO |
|
2014-09-04 |
4 |
AS |
$42.54 |
$238,224 |
D/D |
(5,600) |
559,710 |
|
- |
|
Siegall Clay B |
President and CEO |
|
2014-09-04 |
4 |
OE |
$5.92 |
$33,152 |
D/D |
5,600 |
565,310 |
|
- |
|
Dobmeier Eric |
Chief Operating Officer |
|
2014-08-27 |
4 |
OE |
$12.00 |
$99,996 |
D/D |
8,333 |
99,765 |
|
- |
|
Simpson Todd E |
Chief Financial Officer |
|
2014-08-26 |
4 |
A |
$0.00 |
$0 |
D/D |
17,000 |
168,699 |
|
- |
|
Siegall Clay B |
President and CEO |
|
2014-08-26 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
559,710 |
|
- |
|
Himes Vaughn B |
EVP, Tech. Ops. & Proc. Sci. |
|
2014-08-26 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
67,209 |
|
- |
|
Dobmeier Eric |
Chief Operating Officer |
|
2014-08-26 |
4 |
A |
$0.00 |
$0 |
D/D |
18,000 |
91,432 |
|
- |
|
Boerner Christopher S. |
Executive Vice President, Comm |
|
2014-08-26 |
4 |
A |
$0.00 |
$0 |
D/D |
16,000 |
72,358 |
|
- |
|
Drachman Jonathan G |
CMO & EVP, R & D |
|
2014-08-26 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
66,481 |
|
- |
|
Dobmeier Eric |
Chief Operating Officer |
|
2014-08-25 |
4 |
AS |
$43.55 |
$209,819 |
D/D |
(4,818) |
73,432 |
|
- |
|
Simpson Todd E |
Chief Financial Officer |
|
2014-08-24 |
4 |
S |
$43.55 |
$160,957 |
D/D |
(3,696) |
151,699 |
|
- |
|
Siegall Clay B |
President and CEO |
|
2014-08-24 |
4 |
AS |
$43.55 |
$1,110,804 |
D/D |
(25,507) |
499,710 |
|
- |
|
Himes Vaughn B |
EVP, Tech. Ops. & Proc. Sci. |
|
2014-08-24 |
4 |
AS |
$43.55 |
$144,147 |
D/D |
(3,310) |
52,209 |
|
- |
|
Boerner Christopher S. |
Executive Vice President, Comm |
|
2014-08-24 |
4 |
AS |
$43.55 |
$54,349 |
D/D |
(1,248) |
56,358 |
|
- |
|
Drachman Jonathan G |
CMO & EVP, R & D |
|
2014-08-24 |
4 |
AS |
$43.55 |
$120,718 |
D/D |
(2,772) |
46,481 |
|
- |
|
Siegall Clay B |
President and CEO |
|
2014-08-12 |
4 |
AS |
$40.48 |
$344,090 |
D/D |
(8,500) |
525,217 |
|
- |
|
Siegall Clay B |
President and CEO |
|
2014-08-12 |
4 |
OE |
$5.92 |
$50,320 |
D/D |
8,500 |
533,717 |
|
- |
|
Siegall Clay B |
President and CEO |
|
2014-08-11 |
4 |
AS |
$40.05 |
$108,130 |
D/D |
(2,700) |
525,217 |
|
- |
|
1805 Records found
|
|
Page 37 of 73 |
|
|